Vultaggio Vincent
SEC insider (Form 3/4/5 filer). CIK 0002018766. PAO and PFO at Zentalis Pharmaceuticals, Inc. (ZNTL). 9 reported Form 4/5 transactions since Sep 2024; latest on Feb 10, 2026. Located in SAN DIEGO, CA.
Companies Vultaggio Vincent has filed insider reports for
- Zentalis Pharmaceuticals, Inc. (ZNTL): Officer, PAO and PFO
Vultaggio Vincent
CIK: 0002018766
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Zentalis Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Feb 10, 2026ZNTL
Zentalis Pharmaceuticals, Inc.
SaleDirect6.9K shares at avg. $2.42$17K - Feb 9, 2026ZNTL
Zentalis Pharmaceuticals, Inc.
SaleDirect3.4K shares at avg. $2.39$8K - Feb 6, 2026ZNTL
Zentalis Pharmaceuticals, Inc.
SaleDirect30K shares at avg. $2.43$73K - Feb 3, 2026ZNTL
Zentalis Pharmaceuticals, Inc.
SaleDirect556 shares at avg. $2.52$1K - Feb 2, 2026ZNTL
Zentalis Pharmaceuticals, Inc.
SaleDirect2.5K shares at avg. $2.55$6K - Jan 8, 2026ZNTL
Zentalis Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
100K shares- - Feb 3, 2025ZNTL
Zentalis Pharmaceuticals, Inc.
AwardDirect158.6K shares- - Feb 3, 2025ZNTL
Zentalis Pharmaceuticals, Inc.
SaleDirect2.6K shares at avg. $1.71$4K - Oct 4, 2024ZNTL
Zentalis Pharmaceuticals, Inc.
SaleDirect1.6K shares at avg. $3.18$5K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 10, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | Sale | 6,894 | $2.42 | $16,699 | Direct |
| Feb 9, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | Sale | 3,379 | $2.39 | $8,086 | Direct |
| Feb 6, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | Sale | 29,951 | $2.43 | $72,772 | Direct |
| Feb 3, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | Sale | 556 | $2.52 | $1,398 | Direct |
| Feb 2, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | Sale | 2,540 | $2.55 | $6,477 | Direct |
| Jan 8, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 100,000 | - | - | Direct |
| Feb 3, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | Award | 158,586 | - | - | Direct |
| Feb 3, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | Sale | 2,615 | $1.71 | $4,476 | Direct |
| Oct 4, 2024 | ZNTL Zentalis Pharmaceuticals, Inc. | Sale | 1,603 | $3.18 | $5,098 | Direct |
1-9 of 9 transactions